EGFR-IN-1 displays strong antiproliferative activity against the H1975 cells and the first line mutant HCC827 cells. Antitumor activity. EGFR-IN-1 is an orally active and irreversible L858R/T790M mutant selective EGFR inhibitor. EGFR-IN-1 potently inhibits Gefitinib-resistant EGFR L858R, T790M with 100-fold selectivity over wild-type EGFR.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 8-10 weeks | $ 1000 | |
10 mg | 8-10 weeks | $ 1700 | |
20 mg | 8-10 weeks | $ 2380 | |
50 mg | 8-10 weeks | $ 5195 | |
100 mg | 8-10 weeks | $ 8104 |
Description | EGFR-IN-1 displays strong antiproliferative activity against the H1975 cells and the first line mutant HCC827 cells. Antitumor activity. EGFR-IN-1 is an orally active and irreversible L858R/T790M mutant selective EGFR inhibitor. EGFR-IN-1 potently inhibits Gefitinib-resistant EGFR L858R, T790M with 100-fold selectivity over wild-type EGFR. |
CAS No. | 1625677-63-5 |
Chemical Formula | C28H30N6O4 |
Molecular Weight | 514.586 |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom